GCM
PODD icon

Genus Capital Management’s Insulet PODD Stock Holding History

Genus Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,271
Closed -$361K – 228
2025
Q4 		$361K Sell
1,271
-14,048
-92% -$4.39M 0.04% 162
2025
Q3 		$4.73M Sell
15,319
-700
-4% -$219K 0.55% 64
2025
Q2 		$5.03M Sell
16,019
-989
-6% -$285K 0.64% 53
2025
Q1 		$4.47M Buy
+17,008
New +$4.6M 0.65% 51

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Genus Capital Management's PODD Position: Q1 2026 in Review

Genus Capital Management sold out of Insulet (PODD) in Q1 2026, closing a stake of 1,271 shares — an estimated $361K sold.

Genus Capital Management first reported a position in PODD in Q1 2025 and held it in 4 quarters. The position peaked at $5.03M in Q2 2025. 787 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Genus Capital Management reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • Genus Capital Management sold 1,271 Insulet shares in Q1 2026, an estimated $361K.
  • Genus Capital Management first reported a position in Insulet in Q1 2025 and held it in 4 quarters.
  • Genus Capital Management's Insulet position peaked at $5.03M in Q2 2025.
  • 787 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.